A Novel Decrease of Mrp3 Protein in Liver of β-Thalassemic Mouse

Journal Title: Journal of Advances in Medicine and Medical Research - Year 2016, Vol 14, Issue 10

Abstract

Background: Hepatocytes have a fundamental system of efflux proteins that protect cells from toxic insults. Unconjugated bilirubin at higher concentration is toxic to cells and its intracellular accumulation is limited by the induction of efflux proteins such as Mrp3. In vivo studies showed an induction of hepatic Mrp3 expression in response to non-hemolytic hyperbilirubinemia as a compensatory mechanism to reduce UCB toxicity. Study Design: In the present study, we analyzed the hepatic Mrp3 expression profile during hemolytic hyperbilirubinemia. We used β-thalassemic mouse and WT rodents treated with phenylhydrazine as an animal model of chronic and acute hemolysis, respectively. Results: Unexpectedly, Mrp3 protein was 75% down-regulated in β-thalassemic mouse although Mrp3 mRNA was normal. Mrp3 mRNA was significantly induced in PHZ treated animals while again; Mrp3 protein was 60% down-regulated. Conclusion: For the first time we observed a clear down-regulation for hepatic Mrp3 protein that linked to hemolysis, not to bilirubin. We hypothesize that a similar decrease for hepatic Mrp3 proteins is occur in hemolytic patients such as β-thalassemia.

Authors and Affiliations

Mohammed Qaisiya, Lucia de Franceschi, Achille Iolascon, Claudio Tiribelli, Cristina Bellarosa

Keywords

Related Articles

The Lived Experiences of Persons with Vitiligo: A Phenomenological Research

Aims: This study was aimed to evaluate the lived experiences of vitiligo patients. Study Design: Descriptive phenomenological approach. Place and Duration of Study: Dermatology clinics of Zabol and Zahedan hospitals in...

Cymbopogon citratus Stapf (DC) Extract Ameliorates Atherogenic Cardiovascular Risk in Diabetes-Induced Dyslipidemia in Rats

Aims: Diabetic dyslipidemia is a recognized risk factor for coronary heart disease (CHD). Plant medicinal agents such as Cymbopogon citratus (C. citratus) have shown potential as alternative therapies for reducing cardio...

Escitalopram Usage Pattern in India: A Knowledge, Attitude and Practice Survey among Indian Psychiatrists

Introduction: Escitalopram is a popular and commonly prescribed anti-depressant in routine clinical practice in India. The objective of this survey was to explore knowledge, attitude and practice (KAP) of escitalopram us...

Tuberculosis in an HIV-infected Child in a Developing Country: A Case Report of Diagnosis Challenges

Aims: To highlight the challenges and the diagnostic dilemmas in resource restricted settings to diagnose and treat Tuberculosis (TB), especially when it co-exists with Human immunodeficiency virus (HIV) infection. Pres...

Appropriateness of Indication and Diagnostic Yield of Colonoscopy in a Southern Nigerian Tertiary Hospital

Background and Objectives: For optimum use of resources in an open access system, official guidelines for the appropriate use of colonoscopy have been proposed by the American Society for Gastrointestinal Endoscopy (ASGE...

Download PDF file
  • EP ID EP340702
  • DOI 10.9734/BJMMR/2016/25139
  • Views 82
  • Downloads 0

How To Cite

Mohammed Qaisiya, Lucia de Franceschi, Achille Iolascon, Claudio Tiribelli, Cristina Bellarosa (2016). A Novel Decrease of Mrp3 Protein in Liver of β-Thalassemic Mouse. Journal of Advances in Medicine and Medical Research, 14(10), 1-6. https://europub.co.uk/articles/-A-340702